# VitaFlowTM II Transcatheter Aortic Valve System Study

> **NCT03575039** · NA · UNKNOWN · sponsor: **Shanghai MicroPort CardioFlow Medtech Co., Ltd.** · enrollment: 178 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** VitaFlow II Transcatheter Aortic Valve System

## Key facts

- **NCT ID:** NCT03575039
- **Lead sponsor:** Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08
- **Primary completion:** 2020-12
- **Final completion:** 2024-12
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03575039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03575039, "VitaFlowTM II Transcatheter Aortic Valve System Study". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT03575039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*